APA (7th ed.) Citation

S, K., I, M., K, T., H, K., C, N., K, T., . . . T, K. (2025). Management strategy for congenital hyperinsulinism with atrial septal defect and diazoxide-induced pulmonary hypertension. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 34(3), 188. https://doi.org/10.1297/cpe.2024-0096

Chicago Style (17th ed.) Citation

S, Koizumi, et al. "Management Strategy for Congenital Hyperinsulinism with Atrial Septal Defect and Diazoxide-induced Pulmonary Hypertension." Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology 34, no. 3 (2025): 188. https://doi.org/10.1297/cpe.2024-0096.

MLA (9th ed.) Citation

S, Koizumi, et al. "Management Strategy for Congenital Hyperinsulinism with Atrial Septal Defect and Diazoxide-induced Pulmonary Hypertension." Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, vol. 34, no. 3, 2025, p. 188, https://doi.org/10.1297/cpe.2024-0096.